Cytokinetics Inc’s recently made public that its EVP Research & Development Malik Fady Ibraham unloaded Company’s shares for reported $63960.0 on May 20 ’25. In the deal valued at $31.98 per share,2,000 shares were sold. As a result of this transaction, Malik Fady Ibraham now holds 140,255 shares worth roughly $4.35 million.
Then, Blum Robert I sold 5,000 shares, generating $154,650 in total proceeds. Upon selling the shares at $30.93, the President & CEO now owns 412,629 shares.
Before that, Bhanji Muna sold 1,454 shares. Cytokinetics Inc shares valued at $43,227 were divested by the Director at a price of $29.73 per share. As a result of the transaction, Bhanji Muna now holds 23,510 shares, worth roughly $0.73 million.
Barclays initiated its Cytokinetics Inc [CYTK] rating to an Overweight in a research note published on April 24, 2025; the price target was $55. A number of analysts have revised their coverage, including Citigroup’s analysts, who began to cover the stock in early February with a ‘”a Buy”‘ rating. Stifel began covering CYTK with “Buy” recommendation on January 22, 2025. RBC Capital Mkts started covering the stock on November 08, 2024. It rated CYTK as “an Outperform”.
Price Performance Review of CYTK
On Friday, Cytokinetics Inc [NASDAQ:CYTK] saw its stock fall -0.96% to $31.02. Over the last five days, the stock has gained 1.75%. Cytokinetics Inc shares have fallen nearly -34.06% since the year began. Nevertheless, the stocks have fallen -35.66% over the past one year. While a 52-week high of $61.38 was reached on 01/27/25, a 52-week low of $29.31 was recorded on 05/15/25. SMA at 50 days reached $36.94, while 200 days put it at $47.29.
Levels Of Support And Resistance For CYTK Stock
The 24-hour chart illustrates a support level at 30.38, which if violated will result in even more drops to 29.74. On the upside, there is a resistance level at 31.54. A further resistance level may holdings at 32.06. The Relative Strength Index (RSI) on the 14-day chart is 39.07, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.02, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 57.88%. Stochastics %K at 38.51% indicates the stock is a holding.
